| Login |
Browse by Creator
Jump to: Article | Conference or Workshop Item Number of items: 4. ArticleBurns, A. , McCaddon, A. , Thomas, A. , Ballard, C. , Jacova, C. , Richie, C. , Wilkinson, D. , Ford, G. , Feldman, H. , O'Brien, J. , Warner, J. , Orgogozo, J. , Broich, K. , Knapp, M. , McKeith, M. , Richardson, M. , Purandare, N. , Bullock, R. , Jones, R. , Auriacombe, S. , Lennon, S. , Lliffe, S. and Wilcock, G. (2006) Clinical practice with anti-dementia drugs a consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology , 20 (6). pp. 732-755. Bayer, A. J. , Wilkinson, D. , Paterson, K. R. , Jenkins, L. , Bullock, R. , Donoghue, S. , Millais, S. B. and Jones, R. (2005) Evaluation of the safety and immunogenicity of synthetic Aβ (AN1792) in patients with AD. Neurology, 64. pp. 94-101. H, C. , Howe, I. , Truyen, L. , Bullock, R. , Lilienfield, S. , Zhu, Y. and Wilcock, G. (2003) A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer s Disease. Drugs and Aging, 20 (10). pp. 777-789. Conference or Workshop ItemSoininen, H. , Martin, S. , Bullock, R. , Alhainen, K. , Hager, K. , Jones, R. , Aarsland, D. , Murthy, A. , Zhang, R. and Bahra, R. (2002) First head to head study comparing the efficacy of donepezil and galantamine in Alzheimer's disease. In: 15th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, 5 October 2002. This list was generated on Mon May 20 03:11:22 2013 BST. |
Follow us